The IBD Screen Of The Day helps find top growth stocks based on the unique RS Rating, which measures a stock's technical performance. Stocks with RS Rating above 80 in early stages tend to be market winners. Novocure's recent performance and potential buying opportunities are discussed.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing